In a mouse model of CKD, inhibiting the principal pathway of NADPH oxidase/ROS/NLRP3 inflammasome effectively diminishes the inflammatory response in the kidneys and reduces the extent of fibrosis [81]. Here, NLRP3 is linked to chronic kidney disease.